The dynamics of tumour-vasculature interaction suggests low-dose, time-dense anti-angiogenic schedulings. [electronic resource]
- Cell proliferation Jun 2009
- 317-29 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2184
10.1111/j.1365-2184.2009.00595.x doi
Angiogenesis Inhibitors--therapeutic use Dose-Response Relationship, Drug Humans Models, Theoretical Neoplasms--blood supply Neovascularization, Pathologic--prevention & control